Neurodermatitis

I have been suffering from a skin rash for about 10 years. A large patch of my skin constantly itches, and the skin is thick and feels like leather. I have gone through almost every ointment on the market, and none works. I went to a new doctor and he said that my rash was neurodermatitis and recommended an antidepressant. I was surprised. Have you ever heard of using a mood-altering medication to treat a skin rash?

Content restricted. Requires subscription

Healthy Middle Age Makes a Big Difference

Avoiding certain health problems in middle age dramatically improves your lifetime chances of preventing a heart attack or stroke, a new study finds. The study included about 250,000 people. It looked at a person’s lifetime risk based on their health at certain ages. Researchers put together the numbers from 18 prior studies. To gauge health, they focused on the standard factors that most strongly increase the risk of heart attack or stroke. They are smoking, high cholesterol, high blood pressure and diabetes. The study found that people with none of these risk factors at mid-life had very little chance of a heart attack or stroke in the rest of their lives. An example would be a 45-year-old male nonsmoker with ideal cholesterol and blood pressure, and no diabetes. His chance of ever having a heart attack or stroke would be 1.4%, researchers said.

Content restricted. Requires subscription

Study: Stem Cells May Help Eye Disease

Two women with very limited vision appeared to improve after treatment with embryonic stem cells, researchers report. These cells are removed from human embryos. They can grow into many types of cells. Both women had some vision but were legally blind. Both had macular degeneration. This disease causes loss of central vision. One woman had the common “dry” form. The other woman had a rarer type. Each woman was injected in one eye with embryonic stem cells. Four months later, they showed some improvement in eye tests. For example, both could read more letters on vision charts. Doctors said the treatment appeared to be safe. The women had no signs of rejection or abnormal growths. The journal Lancet published the study online January 23. The Associated Press wrote about it.

Content restricted. Requires subscription